These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8652273)

  • 21. Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia.
    Hale LP; Patel DD; Clark RE; Haynes BF
    J Cutan Pathol; 1995 Dec; 22(6):536-45. PubMed ID: 8835172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schwann cell tumors express characteristic patterns of CD44 splice variants.
    Sherman L; Skroch-Angel P; Moll J; Schwechheimer K; Ponta H; Herrlich P; Hofmann M
    J Neurooncol; 1995 Dec; 26(3):171-84. PubMed ID: 8750183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
    Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44 isoform expression in the diffuse neuroendocrine system. I. Normal cells and hyperplasia.
    Seelentag WK; Komminoth P; Saremaslani P; Heitz PU; Roth J
    Histochem Cell Biol; 1996 Dec; 106(6):543-50. PubMed ID: 8985742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis.
    Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K
    Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of CD44 variant expression in primary breast cancer.
    Foekens JA; Dall P; Klijn JG; Skroch-Angel P; Claassen CJ; Look MP; Ponta H; Van Putten WL; Herrlich P; Henzen-Logmans SC
    Int J Cancer; 1999 Jun; 84(3):209-15. PubMed ID: 10371335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CD44 variants in osteosarcoma.
    Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
    Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
    Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
    Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
    J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
    Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
    Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
    Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SR proteins regulate V6 exon splicing of CD44 pre-mRNA.
    Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H
    BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
    Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C
    Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
    Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
    Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines.
    Southgate J; Trejdosiewicz LK; Smith B; Selby PJ
    Int J Cancer; 1995 Aug; 62(4):449-56. PubMed ID: 7543458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of variant CD44 epitopes in human astrocytic brain tumors.
    Eibl RH; Pietsch T; Moll J; Skroch-Angel P; Heider KH; von Ammon K; Wiestler OD; Ponta H; Kleihues P; Herrlich P
    J Neurooncol; 1995 Dec; 26(3):165-70. PubMed ID: 8750182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
    Kryworuckho M; Diaz-Mitoma F; Kumar A
    Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CD44 splice variants in metastatic and non-metastatic mouse tumour cell lines.
    Tkach T; Li E; Bestagno M; Burrone OR
    Immunol Lett; 1996 Sep; 52(2-3):81-7. PubMed ID: 8905400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.